Figures below are as of 21 Jul 2026. GMP is an unofficial, unregulated indicator of grey-market demand and is not investment advice.
| Grey Market Premium (GMP) | ₹0 |
| Estimated listing gain | +0.0% |
| Estimated listing price | ₹124 |
| Issue price | ₹124 |
| Issue size | ₹29.14 Cr |
| Subscription | 2.27x |
| Open date | 20 Mar 2026 |
| Close date | 24 Mar 2026 |
| Listing date | 30 Mar 2026 |
| Listing at | BSE SME |
| IPO type | SME |
| Registrar | Skyline Financial Services Pvt.Ltd. |
As of 21 Jul 2026, the grey market premium (GMP) for the Speciality Medicines Ltd. IPO is ₹0, implying an estimated listing gain of about +0.0% and an estimated listing price near ₹124. GMP is unofficial and unregulated — it indicates grey-market sentiment, not a guaranteed listing price.
The Speciality Medicines Ltd. IPO is open for subscription from 20 Mar 2026 to 24 Mar 2026. It is expected to list on 30 Mar 2026.
The Speciality Medicines Ltd. IPO is priced at ₹124 per share, with a total issue size of ₹29.14 Cr.
As of 21 Jul 2026, the Speciality Medicines Ltd. IPO is subscribed 2.27x.